Rapt Therapeutics Stock Shares Owned By Institutions
| RAPT Stock | USD 4.04 0.10 2.42% |
RAPT Therapeutics fundamentals help investors to digest information that contributes to RAPT Therapeutics' financial success or failures. It also enables traders to predict the movement of RAPT Stock. The fundamental analysis module provides a way to measure RAPT Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RAPT Therapeutics stock.
RAPT | Shares Owned By Institutions |
RAPT Therapeutics Company Shares Owned By Institutions Analysis
RAPT Therapeutics' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current RAPT Therapeutics Shares Owned By Institutions | 93.97 % |
Most of RAPT Therapeutics' fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RAPT Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
RAPT Shares Owned By Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for RAPT Therapeutics is extremely important. It helps to project a fair market value of RAPT Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since RAPT Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RAPT Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RAPT Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 93% of RAPT Therapeutics are shares owned by institutions. This is 110.51% higher than that of the Biotechnology sector and 97.83% higher than that of the Health Care industry. The shares owned by institutions for all United States stocks is 139.66% lower than that of the firm.
RAPT Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RAPT Therapeutics' direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RAPT Therapeutics could also be used in its relative valuation, which is a method of valuing RAPT Therapeutics by comparing valuation metrics of similar companies.RAPT Therapeutics is currently under evaluation in shares owned by institutions category among related companies.
RAPT Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, RAPT Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to RAPT Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
RAPT Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.4 | ||||
| Current Valuation | 9.24 M | ||||
| Shares Outstanding | 34.9 M | ||||
| Shares Owned By Insiders | 1.84 % | ||||
| Shares Owned By Institutions | 93.97 % | ||||
| Number Of Shares Shorted | 3.22 M | ||||
| Price To Book | 2.18 X | ||||
| Price To Sales | 411.22 X | ||||
| Gross Profit | 1.53 M | ||||
| EBITDA | (123.51 M) | ||||
| Net Income | (116.8 M) | ||||
| Cash And Equivalents | 207.34 M | ||||
| Cash Per Share | 6.99 X | ||||
| Total Debt | 6.91 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 15.97 X | ||||
| Book Value Per Share | 3.76 X | ||||
| Cash Flow From Operations | (97.05 M) | ||||
| Short Ratio | 4.19 X | ||||
| Earnings Per Share | (3.08) X | ||||
| Target Price | 14.83 | ||||
| Number Of Employees | 126 | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 144.5 M | ||||
| Total Asset | 173.33 M | ||||
| Retained Earnings | (484.68 M) | ||||
| Working Capital | 139.95 M | ||||
| Current Asset | 17 K | ||||
| Current Liabilities | 167 K | ||||
| Net Asset | 173.33 M |
About RAPT Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RAPT Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RAPT Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RAPT Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with RAPT Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RAPT Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RAPT Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against RAPT Stock
| 0.48 | MTD | Mettler Toledo Inter | PairCorr |
| 0.43 | A | Agilent Technologies Sell-off Trend | PairCorr |
The ability to find closely correlated positions to RAPT Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RAPT Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RAPT Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RAPT Therapeutics to buy it.
The correlation of RAPT Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RAPT Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RAPT Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RAPT Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out RAPT Therapeutics Piotroski F Score and RAPT Therapeutics Altman Z Score analysis. For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for RAPT Stock analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is RAPT Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.08) | Quarterly Revenue Growth (1.00) | Return On Assets (0.40) | Return On Equity (0.67) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.